PCM
GILD icon

Perkins Capital Management’s Gilead Sciences GILD Stock Holding History

Perkins Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$912K Hold
7,216
– – 0.69% 36
2026
Q1 		$1.01M Sell
7,216
-1,050
-13% -$147K 0.94% 30
2025
Q4 		$1.01M Hold
8,266
– – 0.81% 39
2025
Q3 		$918K Sell
8,266
-67
-0.8% -$7.62K 0.81% 39
2025
Q2 		$924K Sell
8,333
-2,000
-19% -$213K 0.93% 36
2025
Q1 		$1.16M Sell
10,333
-500
-5% -$51.6K 1.22% 23
2024
Q4 		$1M Sell
10,833
-100
-0.9% -$9K 0.89% 39
2024
Q3 		$917K Sell
10,933
-1,500
-12% -$114K 0.86% 38
2024
Q2 		$853K Sell
12,433
-500
-4% -$33.4K 0.8% 40
2024
Q1 		$947K Sell
12,933
-50
-0.4% -$3.85K 0.79% 41
2023
Q4 		$1.05M Sell
12,983
-600
-4% -$46.7K 0.9% 39
2023
Q3 		$1.02M Sell
13,583
-34
-0.2% -$2.62K 1.01% 33
2023
Q2 		$1.05M Hold
13,617
– – 0.91% 38
2023
Q1 		$1.13M Sell
13,617
-200
-1% -$16.6K 1.07% 36
2022
Q4 		$1.19M Sell
13,817
-500
-3% -$39.6K 1.25% 29
2022
Q3 		$883K Sell
14,317
-1,300
-8% -$82K 0.99% 34
2022
Q2 		$965K Sell
15,617
-150
-1% -$9.29K 1% 37
2022
Q1 		$937K Hold
15,767
– – 0.77% 50
2021
Q4 		$1.15M Sell
15,767
-533
-3% -$36.7K 0.77% 47
2021
Q3 		$1.14M Buy
16,300
+900
+6% +$63.2K 0.71% 44
2021
Q2 		$1.06M Buy
15,400
+3,100
+25% +$207K 0.6% 50
2021
Q1 		$795K Buy
12,300
+200
+2% +$12.9K 0.46% 60
2020
Q4 		$705K Buy
12,100
+1,200
+11% +$72.4K 0.46% 56
2020
Q3 		$689K Buy
+10,900
New +$756K 0.63% 49
2020
Q1 		$792K Buy
+10,600
New +$732K 0.96% 39

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perkins Capital Management's GILD Position: Q2 2026 in Review

Perkins Capital Management held its Gilead Sciences (GILD) position steady in Q2 2026 at 7,216 shares worth $912K. The position accounts for 0.69% of the portfolio, ranked #36.

Perkins Capital Management first reported a position in GILD in Q1 2020 and has held it in 25 quarters since. The position peaked at $1.19M in Q4 2022. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Perkins Capital Management held 7,216 shares of Gilead Sciences worth $912K as of Q2 2026.
  • Perkins Capital Management left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.69% of Perkins Capital Management's portfolio in Q2 2026, its #36 holding.
  • Perkins Capital Management first reported a position in Gilead Sciences in Q1 2020 and has held it in 25 quarters since.
  • Perkins Capital Management's Gilead Sciences position peaked at $1.19M in Q4 2022.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.